TELA Bio, Inc.
TELA
$1.30
-$0.02-1.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.92M | -11.26M | -9.21M | -10.37M | -12.60M |
| Total Depreciation and Amortization | 270.00K | 267.00K | 266.00K | 263.00K | 249.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.38M | 1.85M | 2.47M | 1.86M | 1.56M |
| Change in Net Operating Assets | 367.00K | -579.00K | -1.05M | -737.00K | 90.00K |
| Cash from Operations | -7.91M | -9.73M | -7.53M | -8.98M | -10.70M |
| Capital Expenditure | -114.00K | -32.00K | -264.00K | -122.00K | -299.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 5.44M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 318.00K | 170.00K | -5.37M | 0.00 | 366.00K |
| Cash from Investing | 204.00K | 138.00K | -190.00K | -122.00K | 67.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 61.00K | 42.92M | 117.00K | 6.00K |
| Repurchase of Common Stock | -3.00K | -177.00K | -11.00K | -19.00K | -11.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.00K | -116.00K | 42.91M | 98.00K | -5.00K |
| Foreign Exchange rate Adjustments | -152.00K | -134.00K | 182.00K | -188.00K | -12.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.86M | -9.84M | 35.37M | -9.20M | -10.65M |